NSAIDs and Aspirin (eBook)

Recent Advances and Implications for Clinical Management

Angel Lanas (Herausgeber)

eBook Download: PDF
2016 | 1st ed. 2016
XVIII, 263 Seiten
Springer International Publishing (Verlag)
978-3-319-33889-7 (ISBN)

Lese- und Medienproben

NSAIDs and Aspirin -
Systemvoraussetzungen
85,59 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This volume is a state-of-the art resource on the recent advances and clinical management of NSAIDs and aspirin. The text provides a thorough overview of NSAIDS and aspirin, reviewing such topics as pharmacology and mechanisms, clinical effects, and the safety and efficacy of these drugs. It also focuses on the effect of the drugs on the cardiovascular system and in the prevention of GI cancer. Practical recommendations for a safe prescription of NSAIDs are also included. 

Written by experts in the field, NSAIDs and Aspirin: Recent Advances and Implications for Clinical Management is a comprehensive text of great value to gastroenterologists, rheumatologists, cardiologists, oncologists, orthopedists, trauma and internal medicine specialists.  


Prof. Angel Lanas graduated in medicine from the University of Zaragoza, in Zaragoza, Spain, in 1979. He completed postgraduate training in internal medicine at Zaragoza's University Hospital and was awarded his doctor of medicine degree from the University of Zaragoza in 1984. Prof. Lanas took a position as a research fellow at the same university before working as a gastroenterologist staff member at various Spanish hospitals between 1986 and 1999. From 1989 to 1991, Prof. Lanas also joined the Department of Gastroenterology at the University of Alabama at Birmingham, in Birmingham, Alabama, as a visiting professor. He returned to Spain in 1992 as an associate professor of medicine at the University of Zaragoza. In 1999 he became clinical chief of gastroenterology at the University Hospital and in 2006 professor of medicine at the University of Zaragoza.
 
Since 1987, Prof. Lanas has been the recipient of multiple research grants from various Spanish funding bodies. He has also received grants from private foundations and companies for research mainly focused on the adverse effects of various drugs, especially nonsteroidal anti-inflammatory drugs, on the gastrointestinal tract. He is affiliated with multiple national and international gastroenterological associations and is or has been a member of different executive committees for various international studies. 

Since 2000, he has published more than 80 research and review publications in the field of gastroenterology. Prof. Lanas' research interests include acid-, H. pylori- and NSAID-related gastrointestinal diseases. Chemoprevention of GI cancer

Prof. Angel Lanas graduated in medicine from the University of Zaragoza, in Zaragoza, Spain, in 1979. He completed postgraduate training in internal medicine at Zaragoza’s University Hospital and was awarded his doctor of medicine degree from the University of Zaragoza in 1984. Prof. Lanas took a position as a research fellow at the same university before working as a gastroenterologist staff member at various Spanish hospitals between 1986 and 1999. From 1989 to 1991, Prof. Lanas also joined the Department of Gastroenterology at the University of Alabama at Birmingham, in Birmingham, Alabama, as a visiting professor. He returned to Spain in 1992 as an associate professor of medicine at the University of Zaragoza. In 1999 he became clinical chief of gastroenterology at the University Hospital and in 2006 professor of medicine at the University of Zaragoza.  Since 1987, Prof. Lanas has been the recipient of multiple research grants from various Spanish funding bodies. He has also received grants from private foundations and companies for research mainly focused on the adverse effects of various drugs, especially nonsteroidal anti-inflammatory drugs, on the gastrointestinal tract. He is affiliated with multiple national and international gastroenterological associations and is or has been a member of different executive committees for various international studies. Since 2000, he has published more than 80 research and review publications in the field of gastroenterology. Prof. Lanas’ research interests include acid-, H. pylori- and NSAID-related gastrointestinal diseases. Chemoprevention of GI cancer

Section 1. Pharmacology and MechanismsChapter 1. Chemistry, Pharmacodynamics, and Pharmacokinetics of NSAIDsSara Calatayud and Juan Vicente EspluguesChapter 2. Principles, Mechanisms of Action, and Future Prospects of Anti-Inflammatory DrugsBibiana Rius and Joan Clària Section 2. Clinical Effects and Drug SafetyChapter 3. Efficacy of NSAIDs in the Treatment of Rheumatic DiseasesMarc C. Hochberg and Lee S. SimonChapter 4.  Adverse Effects of NSAIDs in the Gastrointestinal Tract: Risk Factors of Gastrointestinal Toxicity with NSAIDsSunny H. Wong and Francis K.L. ChanChapter 5. Adverse Effects of NSAIDs on the Cardiovascular SystemCarmelo Scarpignato and Corrado BlandizziChapter 6.  Safe Prescription of NSAIDs in Clinical PracticeMohammad Yaghoobi and Richard H. HuntSection 3. AspirinChapter 7. NSAIDS and Aspirin: Recent Advances and Implications for Clinical ManagementKarsten Schrör and Michael VoelkerChapter 8. Non-Prescription Analgesic Anti-inflammatory Drugs: Efficacy and SafetyDenis M. McCarthyChapter 9. Low-Dose Aspirin in the Cardiovascular SystemRuben Casado-Arroyo, Angel Lanas, and Pedro BrugadaChapter 10. Adverse Effects of Low-Dose Aspirin in the Gastrointestinal TractKatsunori IijimaChapter 11. Aspirin in the Treatment and Prevention of Cardiovascular Disease: Need for Individual Clinical JudgmentsAngel Lanas and Charles H. HennekensSection 4. NSAIDS and Aspirin in Cancer PreventionChapter 12. Molecular and Experimental Basis for COX-Inhibition in CancerAnnalisa Bruno, Melania Dovizio, and Paola PatrignaniChapter 13. Clinical Effects of NSAIDs and Coxibs in Colon Cancer PreventionElena Piazuelo and Angel LanasChapter 14. Aspirin and the Prevention of Colorectal Cancer Paul J. Lochhead and Andrew T. ChanChapter 15. A Rational Approach for the Use of NSAIDs and/or Aspirin in Cancer Prevention in the Near Future: “Balancing Risk and Benefits”Elizabeth Half, Ahmad Fokra, and Nadir Arber 

Erscheint lt. Verlag 26.8.2016
Zusatzinfo XVIII, 263 p. 29 illus., 27 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizinische Fachgebiete Innere Medizin Rheumatologie
Schlagworte coxibs • COX inhibition • Eicosanoid biology • Pharmacodynamics • Pharmacokinetics
ISBN-10 3-319-33889-7 / 3319338897
ISBN-13 978-3-319-33889-7 / 9783319338897
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 5,4 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich